Liu Jessica, Baker Timothy B, Chen Jingling, Smock Nina, Griffith Nicholas B, Govindan Ramaswamy, Goldberg Paula, Thole Jodi, Daly Kristin, Reddy James, Ramsey Alex T, Bierut Laura J, James Aimee, Schnoll Robert A, Brownson Ross C, Chen Li-Shiun
Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA.
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
J Clin Transl Sci. 2025 Apr 28;9(1):e114. doi: 10.1017/cts.2025.77. eCollection 2025.
Guideline-based tobacco treatment is infrequently offered. Electronic health record-enabled patient-generated health data (PGHD) has the potential to increase patient treatment engagement and satisfaction.
We evaluated outcomes of a strategy to enable PGHD in a medical oncology clinic from July 1, 2021 to December 31, 2022. Among 12,777 patients, 82.1% received a tobacco screener about use and interest in treatment as part of eCheck-in via the patient portal.
We attained a broad reach (82.1%) and moderate response rate (30.9%) for this low-burden PGHD strategy. Patients reporting current smoking ( = 240) expressed interest in smoking cessation medication (47.9%) and counseling (35.8%). As a result of patient requests via PGHD, most tobacco treatment requests by patients were addressed by their providers (40.6-80.3%). Among patients with active smoking, those who received/answered the screener ( = 309 ) were more likely to receive tobacco treatment compared with usual care patients who did not have the patient portal ( = 323) (OR = 2.72, 95% CI = 1.93-3.82, < 0.0001) using propensity scores to adjust for the effect of age, sex, race, insurance, and comorbidity. Patients who received yet ignored the screener ( = 1024) compared with usual care were also more likely to receive tobacco treatment, but to a lesser extent (OR = 2.20, 95% CI = 1.68-2.86, < 0.0001). We mapped observed and potential benefits to the Translational Science Benefits Model (TSBM).
PGHD via patient portal appears to be a feasible, acceptable, scalable, and cost-effective approach to promote patient-centered care and tobacco treatment in cancer patients. Importantly, the PGHD approach serves as a real world example of cancer prevention leveraging the TSBM.
基于指南的烟草治疗很少提供。启用电子健康记录的患者生成的健康数据（PGHD）有可能提高患者的治疗参与度和满意度。
我们评估了2021年7月1日至2022年12月31日在一家肿瘤内科诊所启用PGHD的策略的效果。在12777名患者中，82.1%的患者在通过患者门户网站进行电子签到时接受了关于烟草使用和治疗兴趣的筛查。
对于这种低负担的PGHD策略，我们实现了广泛的覆盖范围（82.1%）和中等的响应率（30.9%）。报告当前吸烟的患者（n = 240）对戒烟药物（47.9%）和咨询（35.8%）表示出兴趣。由于患者通过PGHD提出请求，大多数患者的烟草治疗请求得到了其医疗服务提供者的处理（40.6 - 80.3%）。在当前吸烟的患者中，与没有使用患者门户网站的常规护理患者（n = 323）相比，接受/回答了筛查的患者（n = 309）更有可能接受烟草治疗（OR = 2.72，95%CI = 1.93 - 3.82，P < 0.0001），使用倾向得分来调整年龄、性别、种族、保险和合并症的影响。与常规护理相比，接受但忽略了筛查的患者（n = 1024）也更有可能接受烟草治疗，但程度较小（OR = 2.20，95%CI = 1.68 - 2.86，P < 0.0001）。我们将观察到的和潜在的益处映射到转化科学益处模型（TSBM）。
通过患者门户网站的PGHD似乎是一种可行、可接受、可扩展且具有成本效益的方法，以促进癌症患者以患者为中心的护理和烟草治疗。重要的是，PGHD方法是利用TSBM进行癌症预防的一个真实世界示例。
